Effexus Pharmaceutical Report issue

For profit Phase 2
Founded: Leakwood KS United States (2008)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2010
NCT01129713
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

esomeprazole (nexium) (1 trial)

secretrol (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Barrett Esophagus (Phase 1)

Dyspepsia (Phase 2)

Gastroesophageal Reflux (Phase 2)

Heartburn (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2